As used in this chapter, "investigational drug, biological product, or device" means an investigational or experimental:

1. (1) drug;
2. (2) biological product; or

3. (3) medical device;

   that has successfully completed Phase I of a federal Food and Drug Administration approved clinical trial, but has not been approved for general use by the federal Food and Drug Administration and remains under investigation in a clinical trial.

As added by P.L.2-2015, SEC.3.